Glioblastoma is a devastating disease due in part to its often late-stage diagnosis, rapid progression, and poor survival rates. This case study looks at how GENEWIZ utilized the PacBio® Sequel™ long-read technology to help a customer improve detection of structural variants within glioblastoma samples.
This Case Study discusses:
Generation of thousands of long-reads using PacBio Sequel Single Molecule Real Time (SMRT) technology
Generation of highly accurate consensus sequences
Identification of approximately 20,000 structural variants
Download Case Study
To learn more about our Whole Genome Sequencing services including long-read technology, visit our Whole Genome Sequencing page.